Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Retained Earnings: 2012-2025

Historic Retained Earnings for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to -$190.6 million.

  • CorMedix's Retained Earnings rose 46.02% to -$190.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$190.6 million, marking a year-over-year increase of 46.02%. This contributed to the annual value of -$339.6 million for FY2024, which is N/A change from last year.
  • Latest data reveals that CorMedix reported Retained Earnings of -$190.6 million as of Q3 2025, which was up 36.29% from -$299.2 million recorded in Q2 2025.
  • In the past 5 years, CorMedix's Retained Earnings registered a high of -$190.6 million during Q3 2025, and its lowest value of -$353.1 million during Q3 2024.
  • Its 3-year average for Retained Earnings is -$307.8 million, with a median of -$313.0 million in 2023.
  • Per our database at Business Quant, CorMedix's Retained Earnings decreased by 17.87% in 2024 and then soared by 46.02% in 2025.
  • Over the past 5 years, CorMedix's Retained Earnings (Quarterly) stood at -$245.7 million in 2021, then decreased by 12.09% to -$275.4 million in 2022, then dropped by 14.90% to -$306.9 million in 2023, then fell by 15.03% to -$339.6 million in 2024, then soared by 46.02% to -$190.6 million in 2025.
  • Its last three reported values are -$190.6 million in Q3 2025, -$299.2 million for Q2 2025, and -$319.0 million during Q1 2025.